103586355 : Question 1:
company A: $Eli Lilly and Co (LLY.US)$
company B: $Novo-Nordisk A/S (NVO.US)$
company C: $Pfizer (PFE.US)$
Question 2:
- Decline in COVID-19 Vaccine Sales
Pfizer's COVID-19 vaccine, Comirnaty, was a significant revenue driver during the pandemic. However, as vaccination rates stabilized and demand for booster shots decreased, Pfizer's revenues from this product declined sharply. This reduction in a key revenue stream has been a major factor in the stock's underperformance.

103586355 : $Meta Platforms (META.US)$'s earning prospects are strong, driven by its dominant position in the digital advertising market, large user base, and strategic investments in new technologies. The company's focus on diversifying revenue streams through the Metaverse, VR, AR, and e-commerce initiatives positions it well for long-term growth. However, regulatory challenges and competition remain significant risks. If Meta successfully navigates these challenges and capitalizes on emerging opportunities, it is well-positioned for sustained growth and profitability in the coming years.